References
- Axelsson R. On the serum concentrations and antipsychotic effects of thioridazine, thioridazine side-chain sulphoxide and thioridazine side-chain sulphone, in chronic psychotic patients. Current Therapeutic Research 1977; 21: 587–605
- Blau K., King G. S. Handbook of Derivatives for Chromatography. Heydon and Sons, London 1978; 120
- Bourquin J. P., Schwarb G., Gamboni G., Flsher R., Ruesch H., Guldimann S., Theus V., Schenker E., Renz J. Synthesen auf dem phenothiazin-gebiet-Neue phenothia zinderivate. Helvetica Chimica Acta 1959; 42: 259–281
- Breyer U. Urinary metabolites of 10-[3′-(4′′-methyl-piperazinyl)-propyl]-phenothiazine (per- azine) in psychiatric patients I. Biochemical Pharmacology 1969; 18: 777–788
- Breyer U., Kreft H., Rassner H., Prox A. Formation of sulphone metabolites from chlorpromazine and perazine in man. Drug Metabolism and Disposition 1978; 6: 114–119
- French M. C., Harrison J. M., Inch T. D., Leadbeater L., Newman J., Upshall D. G. The fate of dibenz (b, f)-1,4-oxasepine (CR) in the rat, rhesus monkey and guinea-pig. Part 1 metabolism in vitro. Xenobiotica 1983; 13: 345–359
- Gardos G., Tecce I. J., Hartmann E., Bowers P., Cole J. O. Treatment with mesoridazine and thioridazine in chronic schizophrenia: I Assessment of clinical and e'ectrophy- siologic reponses in refractory hallucinating schizophrenics. Comprehensive Psychiatry 1978; 19: 517–525
- Gaylord M. G. Reduction with Complex Metal Hydrides. Interscience, London 1956; 594
- Gilbert J. M., Millard B. J. Pharmcologically interesting compounds I: high resolution mass spectra of phenothiazines. Organic Mass Spectrometry 1969; 2: 17–31
- Hammer W., Holmstedt B., Sjoqvist, Jorgen V. The metabolism of tremorine— identification of a new biologically active metabolite, N-(4-pyrolidino-2-butyryl)-aminobutyric acid. Biochemical Pharmacology 1968; 17: 1931–1941
- Hallstrom G., Kammerer R. C., Nguyen C. H., Schmitz D. A., Di Stefano E. W., Cho A. K. Phencyclidine metabolism in vitro—the formation of a carbinolamine and its metabolites by rabbit liver preparations. Drug Metabolism and Disposition 1983; 11: 47–53
- Jones N. D. Comprehensive Organic Chemistry, Vol. 3. Scheffield University; Pergamon Press. 1979; 129
- Kaiser C., Swagzdis J. E., Flanagan T. L., Lester B. M., Burghard G. L., Green H., Zirkle C. Metabolism of diphenidol—urinary products in humans and dogs. Journal of Medicinal Chemistry 1972; 15: 1146–1150
- Kanig K., Breyer U. Urinary metabolites of 10-[3′-(4′′-methylpiperazinyl)-propyl]- phenothiazine (perazine) in psychiatric patients. II. Individual metabolite patterns and their changes in the course of treatment. Psychopharmacologia, (Berlin) 1969; 14: 211–220
- Kise M., Oae S. Reaction of sulphoxides with acylating reagents. Bulletin of the Chemical Society of Japan 1970; 43: 1426–1430; 1804–1808
- Krauss D., Otting W., Breyer U. Identification of a urinary metabolite of perazine as piperazine-2,5-dione derivative. Journal of Pharmacy and Pharmacology 1969; 21: 808–813
- Mackay A. V. P., Healey A. F., Baker J. The relationship of plasma chlorpromazine to its 7-hydroxy and sulphoxide metabolites in a large population of chronic schizophrenics. British Journal of Clinical Pharmacology 1974; 1: 425–430
- Mitchard M., Kendall M. J., Chan K. Pethidine N-oxide—a metabolite in human urine. Journal of Pharmacy and Pharmacology 1972; 24: 915
- Muusze R. G., Vanderheeren F. A. J. Plasma levels and half lives of thioridazine and some of its metabolites II—low doses in older psychiatric patients. European Journal of Clinical Pharmacology 1977; 11: 141–147
- Ng C. H., Crammer J. L. Measurement of thioridazine in blood and urine. British Journal of Clinical Pharmacology 1977; 4: 173–183
- Papadopoulos A. S., Chand T. G., Crammer J. L., Lader S. A pilot study of plasma thioridazine and its metabolites in chronically treated patients. British Journal of Psychiatry 1980; 136: 591–596
- Papadopoulos A. S., Crammer J. L., Cowan D. A. Phenolic metabolites of thioridazine in man. Xenobiotica 1985; 15: 303–316
- Poklis A., Wells C. E., Juenge E. C. Thioridazine and its metabolites in post mortem blood, including two stereoisomeric ring sulphoxides. Journal of Analytical Toxicology 1982; 6: 250–252
- Sakalis G., Chan T., Gershon S., Park S. The possible role of metabolites in therapeutic response to chlorpromazine treatment. Psychopharmacologia 1973; 32: 279–284
- Sakalis G., Traficante L. J., Gershon S. Thioridazine metabolism and clinical response—a pilot study. Current Therapeutic Research 1977; 21: 720–724